As of 4:00pm ET
| -0.04 / -0.58%|
The 1 analysts offering 12-month price forecasts for CASI Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +2.19% increase from the last price of 6.85.
The current consensus among 1 polled investment analysts is to Buy stock in CASI Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.